INTRODUCTION
============

Early afterdepolarizations (EADs) are arrhythmogenic membrane potential oscillations that occur before repolarization of the cardiac action potential (AP) is complete. Although the mechanistic link between EADs in single cells and triggered arrhythmias in the heart is still a subject of intense investigation ([@bib36]; [@bib24]; [@bib2]; [@bib11]; [@bib40]; [@bib39]; [@bib41]), it is firmly established that EADs are capable of triggering fatal arrhythmias such as polymorphic ventricular tachycardia, torsade de pointes, and ventricular fibrillation ([@bib40]; [@bib9]; [@bib37]; [@bib1]; [@bib5]), which often exhibit a mixture of focal and reentrant mechanisms ([@bib4]; [@bib25]; [@bib35]; [@bib7]). Not only are EADs capable of generating triggered activity to produce focal arrhythmias, but they are also associated with a prolonged AP duration (APD). Thus, they can markedly increase dispersion of refractoriness in tissue, predisposing to initiation of reentry ([@bib25]; [@bib35]; [@bib7]).

The onset of EADs (i.e., the reversal of the normal repolarization phase of the AP) occurs within a range of the membrane potentials where the steady-state activation and inactivation curves of the L-type Ca^2+^ current (I~Ca,L~) overlap, known as the I~Ca,L~ window current region ([@bib15]). Within this membrane potential range, I~Ca,L~ reactivation plays a key role in reversing the normal repolarization phase during EAD formation ([@bib15]). Although other ionic currents also participate in EAD formation, a regenerative inward current such as I~Ca,L~ is required for EADs to propagate in the tissue ([@bib43]; [@bib7]). Using the dynamic-clamp technique ([@bib10]) in isolated rabbit ventricular myocytes, we recently demonstrated that EADs are highly sensitive to subtle changes in the half-activation or half-inactivation potentials of I~Ca,L~, suggesting that a reduction of the I~Ca,L~ window current may represent an effective maneuver to suppress EADs and normalize APD without blocking the early peak I~Ca,L~ required to maintain a normal excitation--contraction coupling ([@bib18]). The dynamic clamp is a powerful technique that allows one to introduce a model conductance, such as I~Ca,L~, with programmable properties into a cell in real time to study its effects on AP characteristics ([Fig. 1 E](#fig1){ref-type="fig"}). The proof-of-concept provided by our initial study ([@bib18]) prompted us to perform a comprehensive analysis of biophysical parameters influencing the time- and voltage-dependent properties of the window (late) I~Ca,L~ to identify whether additional parameters could be modified to suppress EAD formation and normalize APD. Accordingly, we systematically investigated the slopes of the voltage dependence of activation and inactivation, the noninactivating (or very slowly inactivating) late pedestal current, and the time constants of activation and inactivation, which shape the I~Ca,L~ window current ([Fig. 1, A and C](#fig1){ref-type="fig"}) during the cardiac AP.

The results demonstrate that of all the I~Ca,L~ biophysical parameters explored in this and previous work ([@bib18]), three stand out as highly effective targets both to suppress EAD formation and normalize APD to reduce dispersion of repolarization: the half-activation and half-inactivation potentials and the noninactivating pedestal current. Collectively, these findings provide a drug discovery target to search for new antiarrhythmic agents to suppress EAD-mediated arrhythmias. Moreover, this study recapitulates a novel hybrid experimental--computational approach incorporating the dynamic-clamp technique to predict how subtle alterations in biophysical properties of ionic currents such as I~Ca,L~ affect cardiac electrophysiology and arrhythmogenic phenomena.

MATERIALS AND METHODS
=====================

Ethical approval
----------------

All animal-handling protocols were approved by the UCLA Institutional Animal Care and Use Committee and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.

Electrophysiology
-----------------

3--4-mo-old New Zealand male rabbits were euthanized by an intravenous injection of 1,000 U heparin sulfate and 100 mg/kg sodium pentobarbital; adequacy of anesthesia was confirmed by the lack of pedal withdrawal reflex, corneal reflex, and motor response to pain stimuli. Ventricular myocytes were dissociated using a retrograde Langendorff perfusion system as described previously ([@bib8]), and washed and bathed in Tyrode's solution containing (mM): 136 NaCl, 5.4 KCl, 1 MgCl~2~, 0.33 NaH~2~PO~4~, 1.8 CaCl~2~, 10 glucose, and 10 HEPES, adjusted to pH 7.4. The intracellular solution contained (mM): 110 K-aspartate, 30 KCl, 5 NaCl, 10 HEPES, 0--0.1 EGTA, 5 MgATP, 5 creatine phosphate, and 0--0.05 cAMP adjusted to pH 7.2. EADs were induced by perfusing 600 µM H~2~O~2~ or reducing the external \[K^+^\] from 5.4 to 2.7 mM. All chemicals were purchased from Sigma-Aldrich. All electrophysiological recordings were performed using an Axopatch 200B amplifier (Axon Instruments) in current-clamp mode at ∼34--36°C using 1--2-MΩ borosilicate pipettes (Warner Instruments). Data were acquired and analyzed using custom-made software (G-Patch; Analysis).

Dynamic clamp
-------------

Under dynamic-clamp mode, a virtual I~Ca,L~ with the properties of the native I~Ca,L~ is injected into the myocytes. To predict I~Ca,L~ and its Ca^2+^-dependent inactivation, our ventricular myocyte model also computes intracellular Ca^2+^ cycling. To predict the spatiotemporal distribution of intracellular calcium, average \[Ca^2+^\] was computed in four different cellular compartments, namely the "submembrane space" in proximity of the sarcolemma (*C~s~*), the "bulk myoplasm," the "junctional SR," and "network SR," as described previously ([@bib27]; [@bib19]; [@bib18]). The main Ca^2+^-regulated ionic conductance was also included in the model, i.e., the fast sodium current (I~Na~), the Na^+^/K^+^ pump current (I~NaK~), the Na^+^/Ca^2+^ exchange current (I~NCX~), and the Ca^2+^-dependent slow component of the delayed rectifier potassium channel (I~Ks~). Calcium-modulated currents sense the \[Ca^2+^\] at submembrane space (*C~s~*), which is higher than the global \[Ca^2+^\] (*C~i~*) ([@bib34]). The average *C~s~* is used to calculate Ca^2+^-dependent inactivation in the I~Ca,L~ formulation, whereas *C~i~* was acquired during the course of the experiments to predict the amplitude and shape of the Ca~i~ transient.

In brief, the Ca^2+^ flux into the cell caused by I~Ca,L~ is given by:$$J_{Ca} = g_{Ca}Poi_{Ca}$$$$i_{Ca} = \frac{4P_{Ca}VmF^{2}}{RT}\frac{Cse^{2a} - 0.341\left\lbrack Ca^{2 +} \right\rbrack_{o}}{e^{2a} - 1},$$where *C*~s~ is the submembrane Ca^2+^ concentration in units of millimolar, *P*~Ca~ (0.00054 cm/s) is the Ca^2+^ channel permeability, *V~m~* is the membrane potential, *F* is the Faraday constant, and *T* is temperature.

*P*~O~ was formulated as:$$Po = d \cdot f \cdot q,$$where *d* is the voltage-dependent activation gate, *f* is the VDI gate, and *q* is the Ca^2+^-dependent inactivation gate. The steady states of these gating variables as functions of the membrane potential (*V*~m~) were formulated as follows:$$d_{\infty} = \frac{1}{1.0 + \exp\left( {{- \left( {Vm - dhalf} \right)}/{dslope}} \right)}$$$$f_{\infty} = \frac{1 - pdest}{1.0 + \exp\left( {\left( {Vm - fhalf} \right)/{fslope}} \right)} + pdest$$$$q_{\infty} = \frac{1}{1.0 + \left( \frac{Cs}{cst} \right)^{\gamma}}$$$$\tau_{d}\, = \frac{d_{\infty}\left( {1 - \exp\left( {- Vm - \left( {dhalf + a_{1}} \right)} \right)} \right)}{a_{2}\left( {dslope + a_{2}} \right)\left( {Vm - \left( {dhalf + a_{1}} \right)} \right)}$$$$\tau_{f} = \frac{1}{b_{1}\exp\left( {- b_{2}\left( {Vm - \left( {fhalf + b_{3}} \right)} \right)^{2}} \right) + b_{4}},$$where *dhalf* and *fhalf* are the potentials at half-maximum of activation and inactivation, respectively; *pdest* is the noninactivating pedestal of the inactivation gate; and *dslope/fslope* are the steepness of the voltage dependence of activation and inactivation, respectively. These two parameters are called slope factors (k) in this study, and are related to effective charge (*z*) by RT/*z*, where R is the gas constant and T is temperature. *Cs* is the submembrane \[Ca^2+^\]; *Cst* is the affinity for Ca^2+^ of the inactivation gate; *τ~d~* and *τ~f~* are the time constants of the *d* gate and the *f* gate, respectively; and *a~1~*, *a~2~*, *b~1~*, *b~2~*, *b~3~*, and *b~4~* are additional factors used for fitting. The control parameters in the I~Ca,L~ formulation were determined by fitting formulated current to experimental nifedipine-sensitive I~Ca,L~ records ([@bib18]) using Berkeley Madonna and then implemented for dynamic clamp in RTXI (<http://www.rtxi.org>; [@bib17]). In each experiment, as soon as the whole-cell configuration was obtained, the cell capacitance of the myocyte was measured (usually ranging within 100--150 pF) and entered as one of the parameters of the dynamic-clamp model to scale the computed I~Ca,L~ accordingly to the cell size. The sampling/computation frequency was 10 kHz.

In some experiments, 10% of the computed slow component of the delayed rectifier K^+^ current (I~Ks~) was injected together with I~Ca,L~. I~Ks~ was modeled as in [@bib19].

Data analysis
-------------

APD at 90% repolarization (APD~90~) was calculated using custom-made software, whereas EAD amplitude was calculated manually by measuring the difference in V~m~ from the local minimum where dV/dt is 0 to the peak of the EAD where dV/dt is also 0. In APs that displayed multiple EADs, only the EAD with the largest voltage excursion was included in the analysis. EAD occurrence is reported as the percentage of APs that displayed at least one EAD. Error bars show the SEM.

Computer simulations
--------------------

Single-cell AP simulations were produced using the rabbit ventricular myocyte AP model developed by [@bib19], with some modifications. For details, see the [supplemental text](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp1}.

Online supplemental material
----------------------------

Online supplemental figures show the effects of varying the slope (k) of the steady-state inactivation curve (Fig. S1) and the predicted Ca~i~ transient before and after reduction of I~Ca,L~ pedestal (Fig. S2) under the dynamic clamp. Fig. S3 demonstrates that the reduction of I~Ca,L~ noninactivating component effectively suppressed EADs under hypokalemia condition. Fig. S4 shows results from computer simulation using a model of rabbit myocytes with properties of M, endo, and epi cell layers. Table S1 reports the mean values for EAD occurrence and APD~90~ for different I~Ca,L~ activation and inactivation time constants. Table S2 shows the biophysical parameters of I~Ca,L~ in the dynamic-clamp model for control, H~2~O~2~, and hypokalemia conditions. Tables S3 and S4 provide parameter values for maximal ionic conductances used in the computer simulation using a model of rabbit AP with properties of epi, endo, and M cell layers. The online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.201411288/DC1>.

RESULTS
=======

Sensitivity of EAD occurrence to the noninactivating component of I~Ca,L~
-------------------------------------------------------------------------

In our previous study ([@bib18]), we demonstrated that modest shifts (\<5 mV) in the half-activation and half-inactivation potentials of I~Ca,L~, which reduce the overlap between steady-state activation and inactivation curves (i.e., the window current region; [Fig. 1 A](#fig1){ref-type="fig"}), potently suppressed EADs, without adversely altering APD or the computed intracellular Ca~i~ transient. However, other parameters also affect the I~Ca,L~ window current and its ability to contribute to EAD formation. Using dynamic clamp, we have explored the extent to which the other properties affecting activation and inactivation contribute to EAD formation.

![The I~Ca,L~ window current region and the experimental design for dynamic clamp. (A) Changing steady-state biophysical properties of I~Ca,L~, such as the half-activation potential (V~1/2~ activation), the slope of the activation curve, or the noninactivating pedestal of the inactivation curve has a large impact on the I~Ca,L~ window region, i.e., the area (shaded) subtended by the intersection of the voltage-dependent activation and inactivation curves. (B) The window region bounded by the product of the steady-state activation and steady-state inactivation curves (SS-act × SS-inact). (C) A typical rabbit ventricular myocyte AP after exposure to 600 µM H~2~O~2~, displaying a large-amplitude EAD. EADs often occur within the range of membrane potentials defined by the window current (around −30 to 20 mV). (D) Representative APs for the experimental protocol used in this study: cardiac myocytes (paced at 5 s; left) were exposed to 600 µM H~2~O~2~ to induce EADs (middle). The addition of 20 µM nifedipine blocked the native I~Ca,L~ (right). Under dynamic clamp (E), the myocyte membrane potential is fed into the model, which computes and injects a virtual I~Ca,L~ into the cell in real time and reconstitutes EADs in the continuous presence of H~2~O~2~.](JGP_201411288_Fig1){#fig1}

To induce an EAD regimen, myocytes were paced at 5-s cycle length under current-clamp mode and superfused with 600 µM H~2~O~2~ until EADs appeared consistently. The native I~Ca,L~ was then blocked with 20 µM nifedipine, which eliminated EADs and markedly shortened the APD ([Fig. 1 D](#fig1){ref-type="fig"}). Next, the dynamic clamp was engaged to replace the native I~Ca,L~ (blocked by nifedipine) by injecting, in real time, a I~Ca,L~ computed from [Eqs.1--8](#fd1){ref-type="disp-formula"}, causing EADs to reappear ([Fig. 1 E](#fig1){ref-type="fig"}). The membrane potential of the myocyte was continuously sampled and fed into the dynamic-clamp model, creating a bidirectional relationship between the cell and the model, in real time ([Fig. 1 E](#fig1){ref-type="fig"}). The injected I~Ca,L~ had the properties of the native I~Ca,L~ in the presence of 600 µM H~2~O~2~ ([@bib18]). Importantly, all dynamic-clamp experiments were performed in the continuous presence of H~2~O~2~ or hypokalemia, maintaining a pathological state that resulted in EAD formation.

The inactivation of I~Ca,L~ caused by voltage- and Ca^2+^-dependent mechanisms (voltage-dependent inactivation, VDI, and Ca^2+^-dependent inactivation, CDI, respectively) ([@bib6]) is incomplete during the time course of an AP. This noninactivating component was previously found to be elevated (from ∼3 to ∼10% of the peak current) in myocytes exposed to an EAD-promoting regimen (H~2~O~2~) ([@bib18]), suggesting that this residual current contributes to EAD formation by effectively increasing I~Ca,L~ window region ([Fig. 1, A and B](#fig1){ref-type="fig"}). Motivated by these pieces of evidence, we directly probed EAD sensitivity to changes in the amplitude I~Ca,L~ noninactivating component (pedestal) ([@bib23]; [@bib21]). As demonstrated in [Fig. 2](#fig2){ref-type="fig"}, after inducing EADs in a myocyte by H~2~O~2~ superfusion ([Fig. 2 B](#fig2){ref-type="fig"}), the EADs were abolished by nifedipine ([Fig. 2 C](#fig2){ref-type="fig"}) and reconstituted by injecting a virtual I~Ca,L~ ([Fig. 2 D](#fig2){ref-type="fig"}). Under these conditions, APs were markedly prolonged, displaying a consistent EAD regimen, although with oscillations that tended to be smaller in amplitude than the ones typically observed experimentally ([Fig. 2](#fig2){ref-type="fig"}). Because nifedipine abolishes the Ca~i~ transient, which is important for activating I~Ks~ ([@bib29]; [@bib20]), we compensated by adding 10% of the computed I~Ks~ to the injected current. This maneuver reduced the voltage plateau into a range promoting greater I~Ca,L~ reactivation and larger EAD oscillations ([Fig. 2 E](#fig2){ref-type="fig"}), more closely resembling H~2~O~2~-induced EADs before nifedipine blockade. The reduction of the I~Ca,L~ pedestal from 10 to 4% of the peak completely suppressed EAD occurrence and shortened the APD~90~ from 1,090 ± 80 ms to 197 ± 3 ms ([Figs. 2 F](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}) whether or not EAD amplitude was increased by adding I~Ks~. Importantly, the reduction of the I~Ca,L~ pedestal suppresses the EAD regimen without attenuating the amplitude of the predicted Ca~i~ transient ([Fig. S2](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp2}).

![Potent suppression of EAD by reduction of the noninactivating (pedestal) I~Ca,L~ component. (A) APs recorded from rabbit ventricular myocytes at a pacing cycle length of 5 s at 35--37°C in control conditions. (B) Perfusion of 600 µM H~2~O~2~ to the bath solution--induced EADs within 5--10 min. (C) The addition of 20 µM nifedipine blocked the native I~Ca,L~, shortened APD, and abolished EADs. (D) Under dynamic clamp and in the presence of H~2~O~2~, we evaluated the injection of virtual I~Ca,L~ or (E) the combination of I~Ca,L~ plus 10% of the computed I~Ks~. Note that both conditions regenerate the EAD regimen, although the amplitude of the oscillations tended to be larger with the addition of 10% I~Ks~. (F) Varying a single I~Ca,L~ parameter, the noninactivating (pedestal) component completely abolished EADs, despite the presence of H~2~O~2~.](JGP_201411288_Fig2){#fig2}

![A reduction in the noninactivating (pedestal) I~Ca,L~ potently suppresses EADs and restores APD. (A and B) Enlarged view of the steady-state activation and inactivation curves of I~Ca,L~ shows changes made to the noninactivating component (pedestal). Under dynamic clamp and in the presence of H~2~O~2~, we evaluated the effect of lowering the noninactivating pedestal from 10% (A) to 4% of the peak current (B). (C) The proportion of APs displaying EADs under two different pedestal amplitudes. (D) APD~90~ under two different pedestal amplitudes. Note that lowering the pedestal current to 4% eliminated EADs and restored a normal APD when either I~Ca,L~ only (circles) or I~Ca,L~ plus 10% I~Ks~ (squares) was injected. The means for all experiments are plotted as open rectangles (*n* = 6 from six rabbits). Error bars indicate SEM.](JGP_201411288_Fig3){#fig3}

These results indicate that the reduction of the noninactivating I~Ca,L~ pedestal current can be an effective therapeutic strategy to suppress EADs.

Sensitivity of EADs to the steepness of steady-state activation and inactivation curves
---------------------------------------------------------------------------------------

Another set of parameters affecting the I~Ca,L~ window current region are the steepness of the voltage dependence of activation and inactivation. However, modification of either parameter did not completely suppress EADs, nor did it restore normal APD, in contrast to the consequences of noninactivating pedestal current reduction. After reconstitution of the EADs with dynamic clamp in the presence of H~2~O~2~ in the superfusate, we first examined the effects of altering the slope factor (k) of the voltage dependence of activation from 4 mV (effective valence, *z* = 5.7 e^0^) to 1 mV (*z* = 25.6 e^0^) or 8 mV (*z* = 3.2 e^0^) to increase or decrease, respectively, the steepness of the voltage dependence of activation ([Fig. 4 A](#fig4){ref-type="fig"}). We found that, at greater steepness, EAD amplitudes decreased from 5.6 ± 0.7 mV to 3.1 ± 1 mV (for k = 2 mV, *z* = 12.8 e^0^) or 2.6 ± 0.8 mV (k = 1 mV, *z* = 25.6 e^0^) ([Fig. 4, B and C](#fig4){ref-type="fig"}). Also, for the steepest slope (k = 1 mV, *z* = 25.6 e^0^), the APD became prolonged such that, in some cases, the AP failed to repolarize before the next pacing stimulus (APD \> 5 s) ([Fig. 4 B](#fig4){ref-type="fig"}). Conversely, when the effective charge of the activation curve was reduced from k = 4 mV (*z* = 6.4e^0^) to k = 6 mV (*z* = 4.3e^0^), EAD amplitude increased from 5.6 ± 0.7 mV to 12.3 ± 1.4 mV ([Fig. 4, B and C](#fig4){ref-type="fig"}). This effect was even more pronounced for k = 8 mV (*z* = 3.2e^0^), such that the mean EAD amplitude increased to 21.4 ± 2 mV ([Fig. 4, B and C](#fig4){ref-type="fig"}), although no significant changes in percentage of APs with EADs were observed ([Fig. 4 D](#fig4){ref-type="fig"}), and APD~90~ remained prolonged for these maneuvers ([Fig. 4 E](#fig4){ref-type="fig"}).

![EAD amplitude is sensitive to changes in the slope of the steady-state voltage dependence of activation of I~Ca,L~. (A) Under dynamic clamp and in the presence of H~2~O~2~, we evaluated the effects of varying the slope factor (k) of the steady-state activation curve. Steady-state inactivation properties were unperturbed, whereas the slope of the steady-state activation curve was varied under dynamic clamp from k = 1 mV to k = 8 mV. The set of curves in the center, k = 4 mV, corresponds to the native I~Ca,L~ modified by H~2~O~2~. (B) Representative APs obtained for each k value studied, displaying EADs. For each value of k tested, the mean EAD amplitude (C), EAD occurrence (D), and APD~90~ (E) are shown. Data from individual cells are shown as closed circles, and the means for all experiments are plotted as an open rectangles (*n* = 5--6 cells from five to six rabbits). Error bars indicate SEM. \*, instances when the AP failed to repolarize before the next pacing stimulus are reported as RF (repolarization failure). Note that EAD amplitude grows as k is increased (slope becomes shallower).](JGP_201411288_Fig4){#fig4}

We also investigated the effects of changing the slope of the voltage dependence of inactivation ([Fig. S1 A](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp3}) by increasing or decreasing the effective charge to k = 1 mV (*z* = 25.6 e^0^) or k = 8 mV (*z* = 3.2 e^0^), respectively. We did not observe a significant difference in either EAD amplitude or in percentage of APs with EADs (Fig. S1, C and D). APD~90~ prolonged from 1,104 ± 319 ms to 3,140 ± 771 ms (Fig. S1, B and E) as the steepness of the inactivation curve was reduced from k = 4 mV (*z* = 6.4 e^0^) to k = 8 mV (*z* = 3.2 e^0^) (Fig. S1 A).

Sensitivity of EADs to the kinetics of I~Ca,L~ activation and inactivation
--------------------------------------------------------------------------

We next studied the effects of altering the time constants of I~Ca,L~ activation and inactivation on EAD formation during oxidative stress. Overall, we found that changes in the rates of I~Ca,L~ activation or inactivation by up to 10-fold had limited efficacy at suppressing EADs induced by H~2~O~2~ ([Figs. 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}).

Specifically, in the presence of H~2~O~2~, slowing I~Ca,L~ activation by twofold (τ*~d~* × 2) maintained an average APD~90~ of 1,550 ± 130 ms, and EAD occurrence remained high at 91 ± 4% ([Table S1](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp4}). A 10-fold slowing of I~Ca,L~ activation (τ*~d~* × 10) prolonged APD~90~ from 1,376 ± 200 ms to 2,711 ± 548 ms, whereas EAD occurrence increased from 76 ± 8% to 100% of APs. Conversely, increasing the rate of I~Ca,L~ activation by twofold (τ*~d~* × 0.5; Table S1) or by 10-fold (τ*~d~* × 0.1) had only a modest impact on both APD~90~ (1,122 ± 126 ms or 1,104 ± 165 ms) and EAD occurrence (79 ± 15% or 77 ± 10%), respectively ([Fig. 5](#fig5){ref-type="fig"} and Table S1).

![Time constant of I~Ca,L~ activation has a limited effect on H~2~O~2~-induced EADs. (A) I~Ca,L~ model outputs in response to depolarizing pulses from −80 to 10 mV using three different time constants of activation (*τ*~d~). (B) Representative APs recorded under dynamic-clamp conditions from myocytes in which the endogenous I~Ca,L~ was replaced with a virtual I~Ca,L~ with modified activation time constants. The injected virtual I~Ca,L~ in dynamic clamp is shown in gray under each AP trace. Increasing or decreasing I~Ca,L~ activation rate by a factor of 10 did not significantly shorten APD or suppress EADs. For each value of *τ*~d~ tested, EAD occurrence (C) and APD~90~ (D) are shown. Data from individual cells are shown as closed circles, and the means for all experiments are plotted as open rectangles (*n* = 7 from five to six rabbits). Note that in all cases, APD~90~ remained prolonged (≥500 ms). Error bars indicate SEM. \*, instances when the AP failed to repolarize before the next pacing stimulus are reported as RF (repolarization failure).](JGP_201411288_Fig5){#fig5}

When the rate of VDI in the dynamic-clamp model was increased by twofold (τ*~f~* × 0.5), neither APD~90~ (from 1,376 ± 200 ms to 1,838 ± 435 ms) nor EAD occurrence (from 76 ± 8% to 70 ± 16%) was dramatically altered (Table S1). Accelerating VDI by 10-fold (τ*~f~* × 0.1; [Fig. 6 A](#fig6){ref-type="fig"}) increased APD~90~ (to 2,433 ± 290 ms) ([Fig. 6 D](#fig6){ref-type="fig"}), and EAD occurrence remained high (85 ± 8%; [Fig. 6 C](#fig6){ref-type="fig"} and Table S1). Conversely, decreasing the rate of VDI by twofold (τ*~f~* × 2; [Fig. 6 A](#fig6){ref-type="fig"}) reduced EAD occurrence to 24 ± 14% ([Fig. 6 C](#fig6){ref-type="fig"}), but APD~90~ remained prolonged (802 ± 183 ms; [Fig. 6 D](#fig6){ref-type="fig"}). Decelerating inactivation by 10-fold (τ*~f~* × 10), on the other hand, did not reduce EAD occurrence (73 ± 24% of APs), and significantly prolonged APD~90~ (1,506 ± 102 ms; [Fig. 6, C and D](#fig6){ref-type="fig"}, and Table S1).

![I~Ca,L~ time constant of inactivation has limited efficacy for suppressing EADs induced by H~2~O~2~. (A) I~Ca,L~ model outputs in response to depolarizing pulses from −80 to 10 mV using four different time constants of inactivation (*τ*~f~). (B) Representative APs recorded under dynamic-clamp conditions from myocytes in which the endogenous I~Ca,L~ was replaced with a virtual I~Ca,L~ with modified inactivation time constants. The injected virtual I~Ca,L~ in dynamic clamp is shown in gray under each AP trace. For each value of *τ*~f~ tested, EAD occurrence (C) and APD~90~ (D) are shown. Data from individual cells are shown as closed circles, and the means for all experiments are plotted as open rectangles (*n* = 4--7 from three to five rabbits). A limited favorable effect on EAD occurrence was observed for decreasing *τ*~f~ by a factor of 2; however, on average, APs remained prolonged (\>500 ms). Error bars indicate SEM. \*, instances when the AP failed to repolarize before the next pacing stimulus are reported as RF (repolarization failure).](JGP_201411288_Fig6){#fig6}

Reduction of I~Ca,L~ noninactivating component is effective at suppressing EADs under hypokalemia, another EAD-favoring condition
---------------------------------------------------------------------------------------------------------------------------------

In addition to our previously reported finding that EADs could be suppressed, and the APD could be normalized, by modest shifts of the half-voltage of steady-state activation or inactivation ([@bib18]), the present results indicate that suppressing the noninactivating I~Ca,L~ pedestal current is an effective strategy, whereas the modification of other biophysical parameters affecting the steepness or kinetics of activation and inactivation is unreliable. To ascertain whether reducing I~Ca,L~ pedestal is effective at suppressing EADs caused by a mechanism other than oxidative stress, we also examined its potency at suppressing hypokalemia-induced EADs. As shown previously ([@bib26]), lowering extracellular \[K^+^\] from 5.4 to 2.7 mM readily induced EADs within 5--10 min. Using the same dynamic-clamp approach, the endogenous nifedipine-sensitive current was replaced by a virtual I~Ca,L~, the parameters of which were modified to simulate the effects of hypokalemia on the native I~Ca,L~ ([Table S2](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp5}). The virtual I~Ca,L~ reconstituted EADs were greatly suppressed (*n* = 3) or completely abolished (*n* = 2) by reducing the pedestal component of the virtual I~Ca,L~ from 5% to ≤0.5% ([Fig. S3, C and D](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp6}).

Effects of noninactivating pedestal of I~Ca,L~ on simulated EADs in epicardial, endocardial, and M cell types
-------------------------------------------------------------------------------------------------------------

Across the ventricular wall, there are regional differences in the ionic basis underlying ventricular APs ([@bib3]; [@bib2]). To explore how these regional differences affect the ability of a therapeutic reduction in the I~Ca,L~ pedestal to suppress EADs, we modified the rabbit ventricular AP model to simulate epicardial, endocardial, and M cell layer APs, respectively. When paced at a 5-s cycle length under control conditions, with a 3% I~Ca,L~ pedestal current ([Fig. S4 A](http://www.jgp.org/cgi/content/full/jgp.201411288/DC1){#supp7}), APD~90~ averaged 229, 258, and 268 ms for the epicardial, endocardial, and M cells, respectively. We then simulated the effects of H~2~O~2~ as described above, including increasing the I~Ca,L~ pedestal current to 6%. The APD~90~ prolonged to 540, 504, and 811 ms, respectively, and EADs appeared in all three cell types (Fig. S4 B). When the I~Ca,L~ pedestal current was reduced to 0%, while maintaining all other H~2~O~2~ effects, APD~90~ shortened to 273, 293, and 309 ms, respectively, and EADs disappeared (Fig. S4 C). Thus, suppressing the I~Ca,L~ pedestal current was effective at eliminating EADs regardless of transmural AP heterogeneity.

DISCUSSION
==========

Although many ionic currents can contribute to EAD formation, reactivation of I~Ca,L~ plays a central role in providing a regenerative inward current required for EADs to propagate, thereby causing triggered activity in multicellular tissue ([@bib15]; [@bib14]). The main finding of the present study is that, even though H~2~O~2~ is likely to promote EADs by affecting multiple ionic currents such as late I~Na~ ([@bib28]), the modification of I~Ca,L~ is sufficient to prevent EADs even in the presence of H~2~O~2~. Furthermore, this intervention does not diminish the amplitude of the predicted Ca~i~ transient (Fig. S2) and therefore is expected to maintain normal cell contractility. Conventional Ca^2+^ channel blockers such as nifedipine, which indiscriminately block both peak and window I~Ca,L~, are highly effective at suppressing EADs (e.g., [Fig. 1 D](#fig1){ref-type="fig"}). However, by blocking peak I~Ca,L~, these drugs also potently suppress excitation--contraction coupling, precluding clinical usefulness for EAD suppression.

In this study, we applied the dynamic-clamp technique to systematically evaluate the hypothesis that EADs can be suppressed by selectively targeting the biophysical properties regulating the I~Ca,L~ window current. [Fig. 7](#fig7){ref-type="fig"} summarizes the effects of the various parameter changes on both APD and EAD occurrence, illustrating that three parameter modifications (depolarizing shift of the half-activation potential, hyperpolarizing shift of the half-inactivation potential, and reduction of the pedestal current) both effectively suppress EADs and restore APD toward a normal value. From these findings, we predict that the ideal Ca^2+^ channel agent for suppressing EAD-mediated arrhythmias (drugs or genetic intervention) would leave peak I~Ca,L~, hence excitation--contraction coupling, intact but selectively suppress late I~Ca,L~ in the window region. An important novel contribution of the present study is the finding that the I~Ca,L~ pedestal current has an equivalent promise to the half-activation and half-inactivation potentials as a novel anti-arrhythmic target to suppress EAD formation, which is robust across the spectrum of simulated transmural AP differences in the ventricular epicardial, M cell, and endocardial layers (Fig. S3). Moreover, it is effective for different mechanisms of EAD generation, as H~2~O~2~ primarily causes EADs by increasing inward currents including late I~Na~ and I~Ca,L~ as a result of oxidative CaMKII activation ([@bib33]; [@bib38]; [@bib32]), whereas hypokalemia causes EADs by reducing K^+^ conductances, i.e., I~Kr~, and Na^+^/K^+^ ATPase activity, which in turn causes accumulation of intracellular Na^+^ and Ca^2+^. The finding that selective blockade of the I~Ca,L~ pedestal has potent EAD-suppressing effects is particularly intriguing because of the precedent in Na^+^ channels, in which selective blockers of the late Na^+^ current (I~Na~), which leave the peak I~Na~ intact, are already in clinical use ([@bib16]). Given the overall structural similarities between Na^+^ and Ca^2+^ channels, the likelihood that analogous agents that selectively block late I~Ca,L~ can also be identified seems high. Moreover, because late I~Na~ can also play an important role in EAD formation ([@bib38]; [@bib42]), we can further speculate that the combination of a late I~Na~ blocker with a late I~Ca,L~ blocker might be a particularly efficacious anti-arrhythmic combination to prevent EAD-mediated arrhythmias.

![The effects of modification of I~Ca,L~ time-dependent and steady-state biophysical properties on APD~90~ and EAD formation. 3-D plot showing the APD distribution for each experimental condition (*n* = 4--28 from 4--14 rabbits). The histograms show the percentage of APs that fall within 200-ms bins up to 5 s. APs in control conditions (white) have a narrow duration distribution with most APs ∼250 ms. Under dynamic clamp, in the presence of H~2~O~2~, the APD distribution broadens, with most APs longer than 1 s (red). Changes in the slopes of the steady-state activation (purple) or inactivation (green) curves, or the time constants of activation (cyan) or inactivation (brown), maintain broad APD distributions. A 6% reduction of the pedestal current (blue), a 5-mV leftward shift in the half-inactivation potential (olive), or a 5-mV rightward shift in the half-activation potential (black) restores APD distributions to around 250 ms ([@bib18]). The corresponding EAD occurrence for each condition is shown plotted perpendicular to the z axis and on the same plane as the floor of the histogram. EAD occurrence is plotted as the percentage of APs with EADs in each experimental condition. In control conditions, no EADs are present (white bar). EAD occurrence is high for all maneuvers studied except for a reduction in the pedestal (blue bar), or favorable shifts in the half-inactivation (olive) and half-activation potentials (black).](JGP_201411288R_Fig7){#fig7}

The effects of modifying various I~Ca,L~ parameters on the APD and EAD occurrence observed in this study can be understood in terms of the dynamical theory of EAD formation as a dual Hopf-homoclinic bifurcation ([@bib30]; [@bib22]). In this theory, the membrane voltage oscillations characterizing EADs depend critically on the amount of time that the membrane potential dwells in the window region during repolarization. This dwell time must be long enough for the growth rate of I~Ca,L~ to overcome counterbalancing repolarizing currents such as I~Ks~, thereby generating the upstroke of the EAD. As the membrane potential exceeds the voltage for peak I~Ca,L~ (∼0 mV), the diminishing amplitude of I~Ca,L~ and voltage-dependent growth of I~Ks~ force the repolarization phase of the EAD, with this tug-of-war generating successive oscillations. Our results show that EAD amplitude is a function of the slope of the voltage dependence of I~Ca,L~ activation ([Fig. 4](#fig4){ref-type="fig"}), consistent with the dynamical theory stating that membrane oscillations (EADs) occur because of instability of the I~Ca,L~ in the window current voltage range via a Hopf bifurcation ([@bib30]; [@bib22]). EAD formation is more susceptible to interventions that limit the maximum steady-state amplitude that the late I~Ca,L~ can achieve during repolarization (shifts in half-activation and half-inactivation potential and pedestal current) than to interventions that change the rate of growth (time constants of activation and inactivation) or shape of the window I~Ca,L~ (slopes of inactivation and inactivation). Although EAD occurrence could be diminished with small changes in steady-state parameters (\<5-mV shifts in half-activation and half-inactivation potential or reduction in the pedestal current; [Fig. 7](#fig7){ref-type="fig"}), kinetic parameters required order-of-magnitude changes to produce modest effects, often causing excessive changes in APD ([Figs. 4](#fig4){ref-type="fig"}--[7](#fig7){ref-type="fig"} and S1).

Limitations and Implications
----------------------------

There are several limitations in this experimental--computational approach:

### Rabbit versus human ventricular myocytes.

This study was performed in rabbit ventricular myocytes, which differ in some respects from human myocytes. Although the results from this study need to be validated in human myocytes, previous studies have shown that the I~Ca,L~ properties are generally similar in both species ([@bib13]; [@bib31]), suggesting that suppression of I~Ca,L~ noninactivating component could be an effective therapeutic strategy.

### Virtual I~Ca,L~.

To study how the biophysical properties of I~Ca,L~ affect EAD formation, it was required to replace the endogenous I~Ca,L~ with a computed, "virtual" I~Ca,L~ with tunable parameters under dynamic-clamp conditions. The current injected under the dynamic clamp, although incorporating Ca^2+^-dependent inactivation in response to the virtual Ca~i~ transient in the model, did not trigger SR Ca^2+^ release in the myocytes. Thus, endogenous Ca^2+^-sensitive currents in the myocyte, such as Na^+^/Ca^2+^ exchange and I~Ks~, were not activated. One consequence was that EADs reconstituted after virtual I~Ca,L~ injection were smaller than before nifedipine blockade ([Fig. 2](#fig2){ref-type="fig"}): this could be corrected by injecting additional I~Ks~ via the dynamic clamp to simulate Ca^2+^-induced activation of I~Ks~ ([Fig. 2 E](#fig2){ref-type="fig"}). Importantly, whether or not additional I~Ks~ were injected, reduction of the noninactivated pedestal was equally potent at suppressing EADs and restoring the APD.

### Off-target effects of nifedipine.

Our experimental approach required the full block of the endogenous I~Ca,L~ to correctly evaluate the EAD sensitivity to the relatively small I~Ca,L~ pedestal. We used 20 µM nifedipine, one of the most selective L-type Ca^2+^ channel blockers available. At the concentration used in this work, nifedipine may have had off-target effects, and possibly partially blocked I~to~ conductance ([@bib12]). This effect may have contributed to the reduction of EAD amplitude, as observed in some of the experiments under dynamic clamp (e.g., [Fig. 2 D](#fig2){ref-type="fig"}); however, we were able to effectively restore EAD amplitude by the addition of a fraction of the computed I~Ks~ to the injected current ([Fig. 2 E](#fig2){ref-type="fig"}). We are confident that off-target effects of nifedipine have not biased the overall conclusion of this work, as the consequences of reducing I~Ca,L~ pedestal current were also tested and confirmed in pure computer simulations, presented in Fig. S4.

Despite its limitations, we believe that this approach outlines a useful new strategy for drug discovery, potentially adaptable to high throughput screening of small molecules or genetic interventions, to identify new antiarrhythmic agents. In this context, the dynamic-clamp approach represents a powerful method to move beyond simple screening for indiscriminate ion channel blockers and toward identifying and targeting subtle and selective aspects of ion channel biophysics to guide drug discovery.
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